FI931336A0 - Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk - Google Patents

Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk

Info

Publication number
FI931336A0
FI931336A0 FI931336A FI931336A FI931336A0 FI 931336 A0 FI931336 A0 FI 931336A0 FI 931336 A FI931336 A FI 931336A FI 931336 A FI931336 A FI 931336A FI 931336 A0 FI931336 A0 FI 931336A0
Authority
FI
Finland
Prior art keywords
polyhydroximethylenderivat
bruk
foerfarande foer
deras framstaellning
framstaellning och
Prior art date
Application number
FI931336A
Other languages
English (en)
Other versions
FI931336A (fi
Inventor
Kurt Kesseler
Rudolf Schmidtberger
Stefan Muellner
Ernold Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI931336A0 publication Critical patent/FI931336A0/fi
Publication of FI931336A publication Critical patent/FI931336A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
FI931336A 1992-03-28 1993-03-25 Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk FI931336A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4210220 1992-03-28

Publications (2)

Publication Number Publication Date
FI931336A0 true FI931336A0 (fi) 1993-03-25
FI931336A FI931336A (fi) 1993-09-29

Family

ID=6455312

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931336A FI931336A (fi) 1992-03-28 1993-03-25 Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk

Country Status (12)

Country Link
US (1) US5401498A (fi)
EP (1) EP0563731B1 (fi)
JP (1) JPH0640925A (fi)
KR (1) KR930019220A (fi)
AT (1) ATE130193T1 (fi)
AU (1) AU666173B2 (fi)
DE (1) DE59300925D1 (fi)
DK (1) DK0563731T3 (fi)
ES (1) ES2080549T3 (fi)
FI (1) FI931336A (fi)
GR (1) GR3018185T3 (fi)
NO (1) NO931133L (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6107494A (en) * 1994-09-13 2000-08-22 G.D. Searle And Company Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
US6264937B1 (en) 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6653073B1 (en) * 1998-02-20 2003-11-25 City Of Hope Association of the serotonin transport (HTT) gene with cardiovascular disease and longevity
EA009466B1 (ru) 1998-12-23 2007-12-28 Джи.Ди. Сирл Ллс Ингибитор белка, переносящего эфир холестерила
JP2002533414A (ja) 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
US6569905B1 (en) 1998-12-23 2003-05-27 G.D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
DE69907960T2 (de) 1998-12-23 2004-02-26 G.D. Searle Llc, Chicago Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
ES2200587T3 (es) 1998-12-23 2004-03-01 G.D. Searle Llc Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares.
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
EP1286984A2 (en) 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
US6852753B2 (en) 2002-01-17 2005-02-08 Pharmacia Corporation Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
EP1732516B1 (en) * 2004-03-30 2009-12-30 Relypsa, Inc. Ion binding compositions
EP2538947B1 (en) * 2010-02-24 2016-08-17 Relypsa, Inc. Polyimidazoles for use as bile acid sequestrants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
DE2556759A1 (de) * 1975-12-17 1977-06-30 Hoechst Ag Verfahren zur herstellung von polymeren des vinylencarbonats
DE3330648C2 (de) * 1983-08-25 1986-11-20 Behringwerke Ag, 3550 Marburg Verfahren zum Abtrennen von Lipoproteinen mittels derivatisiertem Polyhydroxymethylen
DE3413904A1 (de) * 1984-04-13 1985-10-24 Hoechst Ag, 6230 Frankfurt Polymerisate auf basis von polyvinylencarbonat und/oder polyhydroxymethylen, verfahren zu ihrer herstellung und ihre anwendung
KR890014100A (ko) * 1988-03-24 1989-10-21 우에하라 아끼라 콜레스테롤 강하제
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
CA2040996A1 (en) * 1990-05-02 1991-11-03 Robert L. Albright Composition and method for controlling cholesterol

Also Published As

Publication number Publication date
ATE130193T1 (de) 1995-12-15
ES2080549T3 (es) 1996-02-01
NO931133L (no) 1993-09-29
EP0563731A1 (de) 1993-10-06
DE59300925D1 (de) 1995-12-21
GR3018185T3 (en) 1996-02-29
AU666173B2 (en) 1996-02-01
EP0563731B1 (de) 1995-11-15
KR930019220A (ko) 1993-10-18
US5401498A (en) 1995-03-28
JPH0640925A (ja) 1994-02-15
AU3544693A (en) 1993-09-30
DK0563731T3 (da) 1996-03-18
FI931336A (fi) 1993-09-29
NO931133D0 (no) 1993-03-26

Similar Documents

Publication Publication Date Title
FI931336A (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
ES2097546T3 (es) Preparaciones cosmeticas desodorantes que contienen esteres di- o trigliceridos.
DE59300654D1 (de) Reinigung von fluorierten Carbonsäuren.
ATE72579T1 (de) Stabiles persaeurebleichmittel.
MX9205981A (es) Administracion transdermica de melatonina.
EP0546160A4 (fi)
NO308508B1 (no) Anvendelse av levobupivacaine i enantiomert overskudd
DE58901906D1 (de) Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz.
TW287948B (fi)
MX9203305A (es) Tratamiento de acidos organo sulfonicos.
NO933590L (no) Injeksjonsopplösninger av mesna
FI892051A (fi) Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofencarbonsyraestrar.
ATE219790T1 (de) Enzymatischer prozess zur herstellung von cefonicid
NO178763C (no) Fremgangsmåte for fremstilling av racemisk og optisk aktiv 1,2,3,4-tetrahydroisochinolin-3-karboksylsyre samt mellomprodukter derav
FI890864A (fi) Anvaendning av 1,4-dihydropyridinderivat.
ES2063581T3 (es) Productos que contienen verapamil y trandolapril.
FI875685A (fi) Foerfarande foer framstaellning av 1,1,2,2-tetrahydroperfluoralkanoler och estrar daerav.
NO944225D0 (no) Styreanordning for optimal bruk av den energi som avgis av et fartöys hovedenergikilde
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
DE69327750D1 (de) Negativ rückgekoppelter Abfühlvorverstärker
DE69203945D1 (de) Herstellung von aliphatischen Dihydroperoxiden.
FR2742337B1 (fr) Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
DE59208872D1 (de) Hydroxylierung von alkylcarbonsäuren mit hilfe von pilzen